Tankyrase-selective inhibitor STP1002 shows preclinical antitumour efficacy without on-target toxicity in the gastrointestinal tract-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tankyrase-selective inhibitor STP1002 shows preclinical antitumour efficacy without on-target toxicity in the gastrointestinal tract

Published:2022-09 Issue: Volume:173 Page:41-51
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Kim Dong Young,Kwon Young-Ju,Seo Won Yong,Kim Uk–Il,Ahn Seohyun,Choi Seong Mi,Bang Hyung Tae,Kim Kyungjin,Kim Jae-Sung

Funder

Korea Research Institute of Chemical Technology

National Research Foundation of Korea

Korea Drug Development Fund

Korea Ministry of Science and ICT

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference35 articles.

1. Wnt signaling in cancer;Zhan;Oncogene,2017

2. Tankyrase inhibitors: potential treatment of hyperproliferative diseases;Abdel-Magid;ACS Med Chem Lett,2014

3. The Wnt signaling pathway in development and disease;Logan;Annu Rev Cell Dev Biol,2004

4. Targeting Wnt signaling in colon cancer stem cells;de Sousa;Clin Cancer Res,2011

5. Linking colorectal cancer to Wnt signaling;Bienz;Cell,2000

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulation of PARP1/2 and the tankyrases: emerging parallels;Biochemical Journal;2024-08-23

2. AXIN2 promotes degradation of AXIN1 through tankyrase in colorectal cancer cells;The FEBS Journal;2024-07-18

3. BET protein–dependent E2F pathway activity confers bell-shaped type resistance to tankyrase inhibitors in APC-mutated colorectal cancer;Cancer Letters;2024-03

4. APC/PIK3CA mutations and β-catenin status predict tankyrase inhibitor sensitivity of patient-derived colorectal cancer cells;British Journal of Cancer;2023-11-15

5. Nonsense mutation suppression is enhanced by targeting different stages of the protein synthesis process;PLOS Biology;2023-11-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3